T63002
2,2,2-Trifluoroethanol
ReagentPlus®, ≥99%
Synonym(s):
Trifluoroethyl alcohol
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Linear Formula:
CF3CH2OH
CAS Number:
Molecular Weight:
100.04
Beilstein/REAXYS Number:
1733203
EC Number:
MDL number:
UNSPSC Code:
12191601
PubChem Substance ID:
NACRES:
NA.21
grade:
reagent
assay:
≥99%
bp:
77-80 °C (lit.)
vapor pressure:
70 mmHg ( 25 °C)
Pricing and availability is not currently available.
Recommended Products
grade
reagent
vapor density
3.5 (vs air)
vapor pressure
70 mmHg ( 25 °C)
product line
ReagentPlus®
assay
≥99%
form
liquid
autoignition temp.
~896 °F
expl. lim.
42 %
dilution
(for general lab use)
refractive index
n20/D 1.3 (lit.)
Looking for similar products? Visit Product Comparison Guide
General description
2,2,2-Trifluoroethanol (TFE) is an organic compound with the chemical formula CF3CH2OH. TFE is a commonly used solvent in organic synthesis. It can also be used as a cosolvent in the experimental study of proteins and peptides.
Application
2,2,2-Trifluoroethanol can be used as a solvent:
- In the synthesis of 2-amino-3-cyano-4H-chromene and tetrahydrobenzo[b]pyran derivatives by catalyst free one-pot condensation of aldehydes, malononitrile and resorcinol or dimedone.
- In the N-formylation of amines with formic acid in the presence of heterogeneous ZIF-8 (zeolitic imidazolate framework) catalyst.
- In the preparation of 2-substituted-2,3-dihydro-4(1H)-quinazolinone derivatives by condensation of anthranilamide with alkyl, aryl, or heteroaryl ketones or aldehydes.
- In the mild and selective oxidation of sulfur compounds using H2O2(hydrogen peroxide).
Features and Benefits
2,2,2-Trifluoroethanol is more acidic than ethanol due to the presence of electronegative trifluoromethyl group.
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Eye Dam. 1 - Flam. Liq. 3 - Repr. 1B - STOT RE 2 Inhalation
target_organs
Blood
Storage Class
3 - Flammable liquids
wgk_germany
WGK 1
flash_point_f
86.0 °F - closed cup
flash_point_c
30 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Hannah A Strobel et al.
Tissue engineering. Part A, 24(19-20), 1492-1503 (2018-05-05)
Tissue-engineered human blood vessels may enable in vitro disease modeling and drug screening to accelerate advances in vascular medicine. Existing methods for tissue-engineered blood vessel (TEBV) fabrication create homogenous tubes not conducive to modeling the focal pathologies characteristic of certain
Jie E Yang et al.
Scientific reports, 10(1), 7939-7939 (2020-05-16)
Enteroviruses support cell-to-cell viral transmission prior to their canonical lytic spread of virus. Poliovirus (PV), a prototype for human pathogenic positive-sense RNA enteroviruses, and picornaviruses in general, transport multiple virions en bloc via infectious extracellular vesicles, 100~1000 nm in diameter, secreted
Erin K Zess et al.
PLoS biology, 17(7), e3000373-e3000373 (2019-07-23)
Autophagy-related protein 8 (ATG8) is a highly conserved ubiquitin-like protein that modulates autophagy pathways by binding autophagic membranes and a number of proteins, including cargo receptors and core autophagy components. Throughout plant evolution, ATG8 has expanded from a single protein
Bei Feng et al.
Biomacromolecules, 13(12), 3917-3925 (2012-11-08)
In tissue engineering research, there has recently been considerable interest in using electrospun biomimetic nanofibers of hybrids, in particular, from natural and synthetic polymers for engineering different tissues. However, phase separation between a pair of much dissimilar polymers might give
Deborah Chang et al.
Molecular & cellular proteomics : MCP, 19(9), 1533-1545 (2020-07-01)
Influenza A virus (IAV) mutates rapidly, resulting in antigenic drift and poor year-to-year vaccine effectiveness. One challenge in designing effective vaccines is that genetic mutations frequently cause amino acid variations in IAV envelope protein hemagglutinin (HA) that create new N-glycosylation
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
